Christian Torres, MD
Interventional Cardiology · Yuma, AZNPI 1356861413
Payments from drug & device makers
Across 128 payments — averaging $69.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3K
- Medtronic$1K
- Abiomed$1K
- Boston Scientific$686
- Abbott$626
- Amgen$442
- plus $2K from 19 others
What the payments were for
- Travel & lodging$3,41639%
- Food & beverage$4,79154%
- Education$6617%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 14 | $2,721 |
| Medtronic | 14 | $1,240 |
| Abiomed | 11 | $1,099 |
| Boston Scientific | 8 | $686 |
| Abbott | 8 | $626 |
| Amgen | 12 | $442 |
| Shockwave Medical, Inc | 4 | $319 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $300 |
| Chiesi USA, Inc. | 6 | $172 |
| Johnson & Johnson | 12 | $165 |
| ZOLL Circulation Inc | 1 | $148 |
| Astellas Pharma US Inc | 4 | $142 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| Endologix LLC | 2 | $123 |
| Novartis | 5 | $98 |
| AstraZeneca(2 entities) | 4 | $95 |
| Cathworks, Inc. | 1 | $84 |
| Penumbra, Inc. | 1 | $63 |
| Pfizer | 2 | $47 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Angiodynamics, Inc. | 1 | $31 |
| Terumo Medical Corporation | 1 | $29 |
| Biotronik Inc. | 1 | $27 |
| Philips North America LLC | 1 | $25 |
| Altathera Pharmaceuticals LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$917
- COREVALVE EVOLUT R$639
- Edwards SAPIEN 3 Transcatheter Heart Valve$498
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$269
- VersaCross Access Solution$247
- Repatha$222
- ENSITE$216
- EnSite Precision Cardiac Mapping System$210
- SYMPLICITY G3$154
- TherOx DS2 Console$148
- Catheter$148
- Downstream Cartridge$148
- OPTIS$144
- WATCHMAN Access System$143
- Watchman$143
- SAPIEN 3 Ultra RESILIA$127
- UPTRAVI$124
- OPSUMIT$124
How this compares
$8,868 in reported general payments places this provider in the 40th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 14 | $286 |
| Amlodipine Besylate | 16 | $156 |
| Losartan Potassium | 13 | $52 |
| Furosemide | 14 | $42 |
| Carvedilol | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Yuma
- Paul SorajjaPhoenix$8.8M
- Thomas WaggonerTucson$4.1M
- Hursh NaikAvondale$2.2M
- Nabil DibGilbert$2.2M
- Timothy ByrnePhoenix$2.1M
- Ashish PershadChandler$1.4M
- Mohamad LazkaniPhoenix$1.1M
- Parminder SinghPhoenix$854K
- Samuel ButmanCottonwood$706K
- Ajay TuliTucson$705K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.